Digital Health

Dr Arwen Podesta explains her PDT patient selection process and the factors she considers before treatment.

Dr Podesta calls on her experience using PDTs with patients to describe what successes and challenges are common.

After completing 6 modules in a digital therapeutic for insomnia, most users met criteria for meaningful treatment response and 40% met criteria for remission.

A digital health intervention delivered via smartphone showed that current anxiety symptoms predicted both current and later depressive symptoms.

Arwen Podesta, MD, provides an overview of how PDTs have evolved over the past 6 years since their introduction into the medical world.

Two experts define prescription digital therapeutics (PDTs) and their role in behavioral care therapy.

Sravanthi Parasa, MD, gastroenterologist at Swedish Gastroenterology, talks about innovations in gastroenterology technology.

A smartphone application designed to identify jaundice in newborns was found to have a similar success rate as the most commonly used conventional screening method.

Researchers published a framework and course design of digital brief therapy for insomnia (dBTI).

Many payers are not familiar with digital therapeutics, indicating the need for better education among payers, said Jayne Hornung, chief clinical officer, pharmacy, MMIT.

Prescription digital therapeutic (PDT) reSET-O, used for opioid use disorder, had similar engagement levels across a broad range of geographic regions in the United States, including both urban and rural areas.

Soumya Vishwanath, PharmD, senior manager of formulary management at Magellan Rx Management, explained what she wishes more people understood about digital therapeutics for behavioral health disorders.

The mobile app Color Me Healthy uses gamified elements to help children with cancer self-report their symptoms throughout treatment; all study participants reported symptoms at least once.

In a session at the 2022 Asembia Specialty Pharmacy Summit, Jayne Hornung, chief clinical officer at Managed Markets Insights & Technology (MMIT), outlined factors driving payer hesitation when it comes to covering prescription digital therapeutics.

Good telehealth is not about the technology, but rather the quality of service from the licensed professional, said Geoffrey Boyce, CEO of Array Behavioral Care.

Health plans and payers have plenty of options for how to analyze the effectiveness of digital therapeutic tools, as there are several effective strategies, according to Soumya Vishwanath, PharmD, of Magellan Rx Management.

In this contributor piece, Gary Hamilton, CEO of InteliChart, the online patient engagement platform, explores how the digital evolution in health care can lead to quality care, convenience, and ongoing patient loyalty.

Discussions regarding health equity and access to care have long been implicated in breast cancer. Here, key opinion leaders discuss the latest progress in clinical trial access, digital therapeutics, and other efforts that aim to ameliorate these care gaps.

When patients had the option of using prescription digital therapeutics, their insurers and employers saved significant money in both direct and indirect medical costs, the 2 studies found.

Emerging technologies have the potential to push psychiatry into a new era of evidence-based care, with improved treatment and access.